APBB1 and Alzheimer disease: In another hAPP-overexpressing mouse model [44], hAPP overexpression was shown to produce elevated mFe65 levels [45], while post mortem analysis of human sporadic AD brain samples revealed that, in the hippocampal areas, an increase in Fe65 immunoreactivity was associated with the severity of the disease [46].